molecules-logo

Journal Browser

Journal Browser

Structural Analysis and Biological Evaluation of Compounds from Fungi—2nd Edition

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 739

Special Issue Editors


E-Mail Website
Guest Editor
1. Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun 130118, China
2. School of Life Sciences, Jilin University, Changchun 130012, China
Interests: fungi; natural compounds; pharmacological efficacy
Special Issues, Collections and Topics in MDPI journals
State Key Laboratory of Food Nutrition and Safety, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China
Interests: fungi; functional compounds; structural analysis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, increasing attention has been paid to the study of edible mushrooms that demonstrate medicinal functions. Mushrooms, such as Ganoderma sichuanense and Lentinula edodes, have been applied in clinical settings. However, although active compounds from mushrooms play a role in certain well-known signaling pathways involved in diseases, their mechanisms of action and target cells/molecules remain unclear.

The goal of this research topic is to identify compounds purified from mushrooms, explore their pharmacological properties, and clarify their mechanism of action and targets. Submitted manuscripts should adhere to the following requirements and scope:

1. The active compounds studied must be purified from mushrooms and subjected to explicit structural analysis. These compounds include, but are not limited to, polysaccharides, alkaloids, flavonoids, and various monomers. Please note that these compounds must have identified chemical structures.

2. The purified and structurally appraised compounds from mushrooms must demonstrate their pharmacological effects, which include, but are not limited to, immune-regulatory, anti-inflammatory, anti-neurodegenerative, anti-oxidative, and anti-tumor properties. Data obtained from in vitro experiments must be confirmed in animal models or preferably in clinical trials.

3. The study must clarify the mechanisms of action of the active compounds with a clear delineation of their targets, such as cells and cytokines associated with pharmacological properties.

Prof. Dr. Di Wang
Dr. Jia Song
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • fungi
  • natural products
  • structure analysis
  • pharmacological properties
  • mechanism
  • disease

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 4619 KiB  
Article
Phenylspirodrimane with Moderate Reversal Effect of Multidrug Resistance Isolated from the Deep-Sea Fungus Stachybotrys sp. 3A00409
by Xinhua Ma, Min Wu, Zhenwei Chen, Fan Cao, Tianhua Zhong, Zhuhua Luo, Zongze Shao, Yonghong Zhang, Limin Chen and Zhiqiang Zhang
Molecules 2024, 29(7), 1685; https://doi.org/10.3390/molecules29071685 - 08 Apr 2024
Viewed by 498
Abstract
Two new phenylspirodrimanes, stachybotrins K and L (1 and 2), together with eight known analogues (310), were isolated from deep-sea-derived Stachybotrys sp. MCCC 3A00409. Their structures were determined by extensive NMR data and mass spectroscopic analysis. Absolute [...] Read more.
Two new phenylspirodrimanes, stachybotrins K and L (1 and 2), together with eight known analogues (310), were isolated from deep-sea-derived Stachybotrys sp. MCCC 3A00409. Their structures were determined by extensive NMR data and mass spectroscopic analysis. Absolute configurations of new compounds were determined through a comparison of their circular dichroism (CD) spectra with other reported compounds. The possible reversal effects of all compounds were assayed in the resistant cancer cell lines. Stachybotrysin B (8) can reverse multidrug resistance (MDR) in ABCB1-overexpression cells (KBv200, Hela/VCR) at the non-cytotoxic concentration. Doxorubicin accumulation assay and molecular-docking analysis reveal that the mechanism of its reversal MDR effect may be related to the increase in the intracellular concentration of substrate anticancer drugs. Full article
Show Figures

Graphical abstract

Back to TopTop